Login / Signup

Effects of Tirzepatide Versus Insulin Glargine on Cystatin C-Based Kidney Function: A SURPASS-4 Post Hoc Analysis.

Hiddo J Lambers HeerspinkNaveed SattarImre PavoAxel HauptKevin L DuffinZhengyu YangRussell J WieseJonathan M WilsonAndrea HemmingwayDavid Z I CherneyKatherine R Tuttle
Published in: Diabetes care (2023)
Tirzepatide slows the eGFR decline rate, supporting a kidney-protective effect.
Keyphrases
  • glycemic control
  • type diabetes
  • small cell lung cancer
  • epidermal growth factor receptor
  • tyrosine kinase
  • adipose tissue
  • skeletal muscle
  • metabolic syndrome